|
|
|
|
|
|
|
|
|
|
AstraZeneca updates on olaparib
"AstraZeneca today (December 20th, 2011) announced that its investigational compound olaparib will not progress into Phase III development for the maintenance treatment of serous ovarian cancer."
Wednesday, December 28, 2011
AstraZeneca - AstraZeneca updates on olaparib
AstraZeneca updates on olaparib
"AstraZeneca today (December 20th, 2011) announced that its investigational compound olaparib will not progress into Phase III development for the maintenance treatment of serous ovarian cancer."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.